Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial

• Status: Completed
• Trial end date: 2021-01-30
• Target enrollment: 0
• Participant gender: All

Summary

The Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial is a single center, double-blind, randomized, active-comparator controlled clinical trial to assess the analgesic efficacy of intercostal nerve block by Liposomal Bupivacaine versus Standard Bupivacaine in subjects undergoing lung resection by robotic or video-assisted thoracoscopic surgery.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of California, San Francisco
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Robotic or Video-Assisted Lung Resection for All Indications

Exclusion Criteria:

• Additional Thoracic Procedures (beyond lung resection and mediastinal lymphadenectomy)

• Extra-Thoracic Procedures

• Hypersensitivity to Amide Local Analgesia

• Cardiac Conduction Abnormalities

• Hepatic Dysfunction

• Preoperative Neuropathic Pain and/or Preoperative Daily Opioid Usage